Senior Director, Search & Evaluation Late TA Lead

​Three Senior Directors of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology, Hematology, and Cardiovascular/Renal therapeutic areas. These leaders will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions.​

**Main** **Responsibilities &** **Accountabilities** ​

+ Serve as the senior S&E leader within the TALT, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.​
+ Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.​
+ Co-lead internal meetings (with Early Search Le...